140P Need for tube feeding in SMA type I patients treated with disease modifying therapies: bulbar function before treatment matters
Giorgia Coratti, E. Mercuri, A. Cerchiari, V. Sansone, Bianca Buchignani(University of Pisa), Maria Carmela Pera(Università Cattolica del Sacro Cuore), Beatrice Berti, Lavinia Fanelli(Università Cattolica del Sacro Cuore), Daniela Leone(Centro Clinico Nemo), Marika Pane(Università Cattolica del Sacro Cuore), Enrico Bertini(Bambino Gesù Children's Hospital), Giulia Stanca(Agostino Gemelli University Polyclinic), Emilio Albamonte(University of Milan), Michela Catteruccia(Bambino Gesù Children's Hospital), Michele Tosi(University of Trento), C. Ausili, Adele D’Amico(Bambino Gesù Children's Hospital), Concetta Palermo(Università Cattolica del Sacro Cuore), Rita De Sanctis(Humanitas University)
Cited by 0
Related Papers
Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection
|Nature Genetics|2006|673
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
|The Lancet Oncology|2017|493
Clinical and Molecular Phenotype of Aicardi-Goutières Syndrome
|The American Journal of Human Genetics|2007|449